Search

Search Constraints

You searched for: Author/Creator Richard, Corentin

Search Results

1. Venous thrombotic events in patients treated with immune checkpoint inhibitors for non-small cell lung cancer: A retrospective multicentric cohort study. Issue 205 (September 2021)

2. 679 High fiber diet modifies gut microbiome, propionate production, intratumor immune response and is associated with outcome in patients with lung cancer treated with immune checkpoint inhibitors. (9th November 2020)

3. 679 High fiber diet modifies gut microbiome, propionate production, intratumor immune response and is associated with outcome in patients with lung cancer treated with immune checkpoint inhibitors. (9th November 2020)

4. Stereotactic Ablative Radiotherapy for oligo-progressive disease refractory to systemic therapy in Non-Small Cell Lung Cancer: A registry-based phase II randomized trial (SUPPRESS-NSCLC). (March 2022)

5. CD4 T cell-intrinsic STING signaling controls the differentiation and effector functions of TH1 and TH9 cells. Issue 1 (28th January 2022)

6. Helicobacter pylori serology is associated with worse overall survival in patients with melanoma treated with immune checkpoint inhibitors. (31st December 2022)

7. ER−/PR+ breast cancer: A distinct entity, which is morphologically and molecularly close to triple‐negative breast cancer. Issue 1 (18th March 2021)

8. Optimized fractionated radiotherapy with anti-PD-L1 and anti-TIGIT: a promising new combination. Issue 1 (25th June 2019)

9. 42: A Competing Risk Analysis of Prognostic Factors for Local and Regional Recurrence and Survival Outcomes in Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Ablative Radiation Therapy. (September 2022)

10. An exceptional metaplastic lobular breast carcinoma diagnosed through exome sequencing. Issue 9 (24th January 2020)